ArticleParasites, hosts and diseases2026
A case of severe strongyloidiasis complicating immunosuppressive therapy initiated for IgA vasculitis.
Article in Parasites, hosts and diseases, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
IgA vasculitis (IgAV) and Strongyloides stercoralis infection may both present with abdominal pain and purpura; however, glucocorticoid, the treatment for IgAV, is a major risk factor for S. stercoralis hyperinfection syndrome and disseminated strongyloidiasis. To date, only 2 cases of IgAV with concurrent S. stercoralis infection have been reported globally, both in children. We report a 72-year-old man presenting with abdominal pain and purpura. Diagnosed with IgAV during this admission, he received glucocorticoid therapy. However, the patient's condition did not improve as expected. Subsequently, S. stercoralis was detected in the patient's sputum and stool. We report the first adult case of IgAV with concurrent S. stercoralis infection, highlighting the importance of screening patients with IgAV for strongyloidiasis before initiating immunosuppressive therapy.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.